Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

China flag China · Delayed Price · Currency is CNY
10.98
+0.16 (1.48%)
Apr 29, 2026, 3:00 PM CST
Market Cap4.82B +9.3%
Revenue (ttm)1.79B +1.9%
Net Income306.52M +12.2%
EPS0.70 +12.9%
Shares Out439.08M
PE Ratio15.68
Forward PE13.23
Dividend0.25 (2.31%)
Ex-Dividend DateJan 16, 2026
Volume9,438,200
Average Volume9,516,706
Open10.85
Previous Close10.82
Day's Range10.77 - 11.10
52-Week Range9.48 - 13.50
Beta0.45
RSI52.57
Earnings DateApr 25, 2026

About SHA:603998

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infective drugs. The company's main products include Xuesetong dispersible tablets, Xuesetong tablets, Garcinia bone-strengthening tablets, Dieda Huoxue ca... [Read more]

Sector Healthcare
Founded 2002
Employees 1,807
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603998
Full Company Profile

Financial Performance

In 2025, SHA:603998's revenue was 1.75 billion, a decrease of -1.75% compared to the previous year's 1.78 billion. Earnings were 306.39 million, an increase of 20.05%.

Financial Statements